SCHEMBL28832845

SCHEMBL28832845

Cc1ccc(S(=O)(=O)n2cc(C3CC3)cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
GRM4 Q14833 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ACHE P22303 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PKM P14618 2/20 0.41
ALDH1A1 P00352 3/20 0.41
MMP2 P08253 1/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAPT P10636 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4993025 0.79 GRM4 (0.51) SMN1; SMN2GRM4NPSR1MEN1KMT2A
SCHEMBL3666257 0.79 GRM4 (0.42) SMN1; SMN2GRM4NPSR1ACHEMEN1
SCHEMBL2574273 0.75 GRM4 (0.48) SMN1; SMN2GRM4MEN1KMT2AL3MBTL1
SCHEMBL29493429 0.75 GAA (0.53) SMN1; SMN2GRM4MEN1KMT2APKM
SCHEMBL422433 0.75 GRM4 (0.48) SMN1; SMN2GRM4MEN1KMT2APKM
SCHEMBL1278809 0.75 MEN1 (0.54) SMN1; SMN2GRM4MEN1KMT2APKM
SCHEMBL27463601 0.75 GRM4 (0.51) SMN1; SMN2GRM4MEN1KMT2APKM
SCHEMBL14920592 0.75 GRM4 (0.51) SMN1; SMN2GRM4MEN1KMT2AL3MBTL1
SCHEMBL28229556 0.73 ACHE (0.44) SMN1; SMN2NPSR1ACHEMEN1KMT2A
SCHEMBL3439397 0.73 GRM4 (0.46) SMN1; SMN2GRM4MEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103958473-B Amide compound, composition and application thereof ADVINUS THERAPEUTICS LTD. (IN) 2016-11-30 CN disclosed